Alkem Laboratories: M/s. Alkem Laboratories Limited has appointed Dr. Amrut Naik as the Chief Executive Officer (CEO) and Key…
Alkem Laboratories (ALKEM) filed a disclosure titled "M/s. The company is valued at about ₹61,636 crore.
What happened
Alkem Laboratories (ALKEM) filed a disclosure with the exchanges on 3 November 2026 at 01:34 PM titled "M/s. Alkem Laboratories Limited has appointed Dr. Amrut Naik as the Chief Executive Officer (CEO) and Key Managerial Personnel of the Company with effect from".
Company snapshot
Alkem Laboratories is a mid-cap company in the Healthcare sector, with a market value of about ₹61,636 crore.
The stock last traded at ₹5,155, against a 52-week range of ₹4,811–₹5,933.5 (13.1% below the high).
Before this filing the shares had moved −2.6% over the month and −11.1% over three months. Average daily turnover over the last 20 sessions was about ₹66.6 crore.
Promoters held 49.70% at the end of Q1 FY27, down 1.50% points from the previous quarter. Foreign institutions owned 10.42% and domestic institutions 22.63%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 3,371 | 664.3 | 55.56 |
| Q2 FY26 | 4,001 | 765.1 | 63.99 |
| Q3 FY26 | 3,737 | 636 | 53.19 |
| Q4 FY26 | 3,603 | 236.5 | 19.77 |
| Q1 FY27 | 3,740 | 520 | 43.49 |
What history shows
BCEIE's records show 7 previous management change filings from the company since May 2026.
After those filings, the stock fell 0.2% on average the next trading day and was down 0.5% on average after five days (6 filings with price data).
Across 113 similar disclosures by other Healthcare companies, shares moved +1.0% on average the next day and +1.8% over five days; 48% of them rose the next day.
Market-wide, 4,129 management change filings with an impact score of 50 or more saw an average next-day move of −0.1%, with 44% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 12 Oct 2026 | Herewith intimation for appointment of Mr. Laxmikant Tiwari and Mr.… | −0.1% | — |
| 24 Sept 2026 | Resignation of Director/KMP/SMP | −2.6% | — |
| 24 Sept 2026 | Change in Key Managerial Personnel Resignation of Chief Financial… | −2.6% | — |
| 15 Sept 2026 | Appointment of Dr. Shubhadeep Sinha as Senior Management Personnel… | +3.6% | +5.0% |
| 3 Aug 2026 | Management change | −0.2% | −3.1% |
What to watch
- The appointment of a successor and any change in strategy or guidance.
In the news
Recent coverage elsewhere (links open the original publisher):
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.